For Immediate Release
March 14, 2017
Senate approves bill to tighten reporting of toxicology screenings
FRANKFORT — A bill to tighten the reporting of toxicology screenings by Kentucky hospitals passed the state Senate today, clearing its way to become law pending the signature of Gov. Matt Bevin.
House Bill 314, which was approved by the House of Representatives late last month, requires certain hospitals to report positive drug screenings to the state’s Cabinet for Health and Family Services, including results from newborn babies who might have been exposed to controlled substances by their mothers prior to birth. The measure is part of an ongoing effort to fight prescription drug abuse in Kentucky.
The bill also permits federal prosecutors and medical professionals, including pharmacists, to use the state’s KASPER (Kentucky All Schedule Prescription Electronic Reporting) database containing reports of misuse of controlled substances.
“For the KASPER system to be effective, we need to stay on top of it,” said Sen. Danny Carroll, R-Paducah. “We need every tool available to us.”
The bill passed the Senate 33-3 and now goes to the Governor’s desk for his consideration.
HB 314 :
AN ACT relating to controlled substance monitoring.
Amend KRS 218A.202 to require certain hospitals to report positive toxicology screens to the Cabinet for Health and Family Services; permit federal prosecutors and agents to use KASPER; permit practitioners or pharmacists to review KASPER reports of birth mothers of potentially drug-exposed infants; remove a pilot program relating to real-time electronic monitoring; make other technical corrections; amend KRS 218A.240 to conform.